An integrated valuation model for payer and investor
Background In order to optimize positioning and associated drug price for both payer and investor, it is for a company essential to forecast the potential market access attractiveness for the new drug for different indications at the early onset of the clinical development program. This analysis mus...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
MDPI AG
2022-12-01
|
| 丛编: | Journal of Market Access & Health Policy |
| 主题: | |
| 在线阅读: | https://www.tandfonline.com/doi/10.1080/20016689.2022.2080631 |
| 标签: |
没有标签, 成为第一个标记此记录!
|